Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects
- PMID: 29398414
- DOI: 10.1016/j.dld.2017.12.018
Nonalcoholic fatty liver disease as a sentinel marker for the development of diabetes mellitus in non-obese subjects
Abstract
Background: Non alcoholic fatty liver disease (NAFLD) is associated with substantial cardiometabolic morbidity.
Aims: We evaluated the long-term extrahepatic complications of NAFLD and sought to evaluate NAFLD in non-obese subjects.
Methods: A total of 2920 participants were retrospectively selected from a health check-up center in 2000, and followed through to December 2010. NAFLD was diagnosed using ultrasonography. Subjects were stratified according to body mass index, NAFLD, and metabolic syndrome.
Results: The prevalence of non-obese NAFLD subjects and metabolically unhealthy non-obese subjects was 14.4% and 8.7%, respectively. In the multivariate analysis, non-obese NAFLD subjects had a significantly higher risk for diabetes mellitus (DM; HR 2.69, 95% CI 1.72-4.20, P < 0.001); no increase was observed for hypertension or cardiovascular disease. Metabolically unhealthy non-obese subjects had a significantly higher risk for hypertension (HR 2.75, 95% CI 2.02-3.74, P < 0.001), DM (HR 5.72, 95% CI 3.68-8.89, P < 0.001), and cardiovascular disease (HR 2.93, 95% CI 1.53-5.63, P = 0.001). Subgroup analysis of non-obese subjects showed that NAFLD, without metabolic syndrome, conferred a higher risk for DM (HR 3.60, 95% CI 2.03-6.39, P < 0.001).
Conclusion: Non-obese subjects with NAFLD are at a higher risk for DM independent of metabolic syndrome.
Keywords: Insulin resistance; Metabolic syndrome; Obesity.
Copyright © 2017 Editrice Gastroenterologica Italiana S.r.l. All rights reserved.
Comment in
-
From a fatty liver to a sugary blood.Dig Liver Dis. 2018 Apr;50(4):378-380. doi: 10.1016/j.dld.2018.01.126. Epub 2018 Feb 2. Dig Liver Dis. 2018. PMID: 29422241 No abstract available.
Similar articles
-
Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.Vojnosanit Pregl. 2016 Oct;73(10):910-20. doi: 10.2298/VSP150514093P. Vojnosanit Pregl. 2016. PMID: 29327896
-
Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.Clin Gastroenterol Hepatol. 2017 Oct;15(10):1604-1611.e1. doi: 10.1016/j.cgh.2017.04.045. Epub 2017 May 26. Clin Gastroenterol Hepatol. 2017. PMID: 28554682
-
Improvement of Nonalcoholic Fatty Liver Disease Reduces the Risk of Type 2 Diabetes Mellitus.Gut Liver. 2019 Apr 17;13(4):440-449. doi: 10.5009/gnl18382. Gut Liver. 2019. PMID: 30970431 Free PMC article.
-
Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients.Aliment Pharmacol Ther. 2017 Jul;46(2):85-95. doi: 10.1111/apt.14112. Epub 2017 May 2. Aliment Pharmacol Ther. 2017. PMID: 28464369 Review.
-
Non-alcoholic fatty liver disease and hypertension: coprevalent or correlated?Eur J Gastroenterol Hepatol. 2018 Sep;30(9):979-985. doi: 10.1097/MEG.0000000000001191. Eur J Gastroenterol Hepatol. 2018. PMID: 30048367 Review.
Cited by
-
Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis.BMC Med. 2024 Mar 6;22(1):101. doi: 10.1186/s12916-024-03315-0. BMC Med. 2024. PMID: 38448943 Free PMC article.
-
Associations of advanced liver fibrosis with heart failure with preserved ejection fraction in type 2 diabetic patients according to obesity and metabolic goal achievement status.Front Endocrinol (Lausanne). 2023 Oct 24;14:1183075. doi: 10.3389/fendo.2023.1183075. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37941902 Free PMC article.
-
Therapeutic Potentials of Reducing Liver Fat in Non-Alcoholic Fatty Liver Disease: Close Association with Type 2 Diabetes.Metabolites. 2023 Apr 4;13(4):517. doi: 10.3390/metabo13040517. Metabolites. 2023. PMID: 37110175 Free PMC article. Review.
-
Assessing the longitudinal association between the GGT/HDL-C ratio and NAFLD: a cohort study in a non-obese Chinese population.BMC Gastroenterol. 2022 Dec 5;22(1):500. doi: 10.1186/s12876-022-02598-y. BMC Gastroenterol. 2022. PMID: 36471271 Free PMC article.
-
Association between serum uric acid-to-creatinine ratio and non-alcoholic fatty liver disease: a cross-sectional study in Chinese non-obese people with a normal range of low-density lipoprotein cholesterol.BMC Gastroenterol. 2022 Sep 14;22(1):419. doi: 10.1186/s12876-022-02500-w. BMC Gastroenterol. 2022. PMID: 36104672 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
